Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

OptimizeRx (OPRX) Return on Sales: 2009-2024

Historic Return on Sales for OptimizeRx (OPRX) over the last 16 years, with FY2024 value amounting to 0.17%.

  • OptimizeRx's Return on Sales rose 4600.0% to 0.03% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.04%, marking a year-over-year increase of 4000.0%. This contributed to the annual value of 0.17% for FY2024, which is 800.0% up from last year.
  • According to the latest figures from FY2024, OptimizeRx's Return on Sales is 0.17%, which was up 800.0% from 0.25% recorded in FY2023.
  • In the past 5 years, OptimizeRx's Return on Sales registered a high of 0.01% during FY2021, and its lowest value of 0.25% during FY2023.
  • Over the past 5 years, OptimizeRx's median Return on Sales value was 0.17% (recorded in 2024), while the average stood at 0.13%.
  • In the last 5 years, OptimizeRx's Return on Sales skyrocketed by 800bps in 2020 and then tumbled by -1900bps in 2022.
  • Annual analysis of 5 years shows OptimizeRx's Return on Sales stood at 0.05% in 2020, then surged by 112bps to 0.01% in 2021, then tumbled by -3069bps to 0.18% in 2022, then tumbled by -34bps to 0.25% in 2023, then skyrocketed by 32bps to 0.17% in 2024.
  • Its Return on Sales was 0.17% in FY2024, compared to 0.25% in FY2023 and 0.18% in FY2022.